search
Back to results

Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior. (PACKING)

Primary Purpose

Autism Spectrum Disorder

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Dry sheet Therapeutic body wraps
WET sheet Therapeutic body wraps
Sponsored by
University Hospital, Lille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Autism Spectrum Disorder focused on measuring Autism, Therapeutic body wraps

Eligibility Criteria

5 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • a current diagnosis of autism, Asperger syndrome, atypical autism according ICD-10 criteria confirmed by specialized clinical assessment;
  • presenting severe behavioural disturbances such as hetero and self-injurious behaviours, automutilation, severe motor hyperactivity, severe stereotypies.
  • having a systematically consultation by a neuro pediatric.

Exclusion Criteria:

  • children with known organic syndrome and/or non-stabilized neuropediatric (e.g. seizures) or medical (e.g. diabetes mellitus) comorbidities.
  • patients with stabilized seizure condition, antiepileptic medication should be stable for at least 4 weeks.

Sites / Locations

  • Centre de Santé Mentale Angevin
  • Centre Hospitalier d'Arras
  • Centre Hospitalier Robert Ballanger
  • Centre Hospitalier Montfavet
  • Institut Départemental Albert Calmette
  • Centre Hospitalier de Douai
  • Etablissement Public de Santé Roger Prévot
  • Centre Hospitalier de Lens
  • Hôpital Fontan, CHRU
  • Institut Médico-éducatif
  • Etablissement de Santé Maison Blanche
  • Groupe Hospitalier Pitier-Salpêtrière
  • Etablissement Public de Santé Mentale Val de Lys-Artois

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

DRY group

WET Group

Arm Description

Dry sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.

Wet sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.

Outcomes

Primary Outcome Measures

Aberrant Behavior Checklist (ABC) irritability score
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score Irritability of the scale ABC

Secondary Outcome Measures

ABC hyperactivity score
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score hyperactivity of the scale ABC
ABC lethargy score
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score lethargy of the scale ABC
ABC inappropriate speech score
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score inappropriate speech of the scale ABC
ABC stereotypic behavior score
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score stereotypic behavior of the scale ABC
ABC Total score
Measure the reduction in the intensity of the behavioral disorders objectified by the total score of the scale ABC
Child Autism Rating Scale (CARS)
Measure the decrease in the intensity of autistic symptoms
Clinical Global Impression-Improvement (CGI-I)
Measure the global clinical outcome
Clinical Global Impression-Severity (CGI-S)
Measure the global clinical outcome

Full Information

First Posted
May 22, 2017
Last Updated
May 22, 2017
Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT03164746
Brief Title
Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.
Acronym
PACKING
Official Title
Demonstration of the Effectiveness of Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism Spectrum Disorder With Severe Injurious Behavior.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
December 2007 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille
Collaborators
Ministry of Health, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Severe injurious behaviors in children with autism spectrum disorder are challenging. First line treatment approaches include behavioral techniques but pharmacotherapy is frequently required despite frequent adverse effects in youths. Therapeutic body wraps has been reported in small series or case reports, but has never been assessed in the context of a randomized controlled trial. The present study is an exploratory, multicenter, randomized, controlled, open label with blinded outcome assessment (PROBE design) trial of the effect of wet versus dry therapeutic body wraps in children presenting with autism spectrum disorder and severe injurious behavior.
Detailed Description
Packing therapy has never been assessed, namely in children with severe injurious behavior and autism spectrum disorder. The aim of the present study is to evaluate the beneficial effect of wet versus dry therapeutic body wraps through an exploratory randomized controlled open label blinded outcome assessment approach. The primary objective is the comparison of change in ABC irritability scores from baseline to 3 months between the two groups. According to the potential recruitment, we plan to recruit 30 subjects in each group. This sample size could allow us to detect a minimum effect size of 0.74 between the 2 groups (considered large in literature) with a power of 80% (two-sided test and type I error of 5%). As described elsewhere, wet or dry session will be organized through twice-a-week sessions for a 3-month duration. Comparison in primary outcome (ABC irritability score) between the 2 groups will be performed using Analysis of Covariance (ANCOVA) adjusted for the baseline value. The standardized difference (effect size) will be computed taking into account the adjustment for baseline and its 95% confidence interval will be estimated using a bootstrap resampling. The validity of the ANCOVA model will be checked by examining the model residuals. The same methodology will be used for the secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder
Keywords
Autism, Therapeutic body wraps

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DRY group
Arm Type
Active Comparator
Arm Description
Dry sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.
Arm Title
WET Group
Arm Type
Experimental
Arm Description
Wet sheet therapeutic body wraps will be conducted through twice-a-week sessions for a 3-month duration. Sessions take place in the same quiet room and they usually last 45 minutes each up to 1 hour depending on the patient's response. During sessions, the patient wearied a bathing suit. Sessions were conducted under the supervision of an occupational therapist and involved at least two members of the patient's care team.
Intervention Type
Other
Intervention Name(s)
Dry sheet Therapeutic body wraps
Intervention Description
At the beginning of the session, the patient's consent to proceed was orally obtained, as no session was compulsory. The therapists checked behavioral manifestations of refusal. Then, the patient was first wrapped in Dry damp sheets (cold phase) and covered up with a rescue and a dry blanket. Afterward the body spontaneously warmed up (warm phase). The patient was then invited to freely express his feelings.
Intervention Type
Other
Intervention Name(s)
WET sheet Therapeutic body wraps
Intervention Description
At the beginning of the session, the patient's consent to proceed was orally obtained, as no session was compulsory. The therapists checked behavioral manifestations of refusal. Then, the patient was first wrapped in wet damp sheets (cold phase) and covered up with a rescue and a dry blanket. Afterward the body spontaneously warmed up (warm phase). The patient was then invited to freely express his feelings.
Primary Outcome Measure Information:
Title
Aberrant Behavior Checklist (ABC) irritability score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score Irritability of the scale ABC
Time Frame
Baseline and 3 months
Secondary Outcome Measure Information:
Title
ABC hyperactivity score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score hyperactivity of the scale ABC
Time Frame
Baseline,1-month, 2-month and 3-months
Title
ABC lethargy score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score lethargy of the scale ABC
Time Frame
Baseline,1-month, 2-month and 3-months
Title
ABC inappropriate speech score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score inappropriate speech of the scale ABC
Time Frame
Baseline,1-month, 2-month and 3-months
Title
ABC stereotypic behavior score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the sub-score stereotypic behavior of the scale ABC
Time Frame
Baseline,1-month, 2-month and 3-months
Title
ABC Total score
Description
Measure the reduction in the intensity of the behavioral disorders objectified by the total score of the scale ABC
Time Frame
Baseline,1-month, 2-month and 3-months
Title
Child Autism Rating Scale (CARS)
Description
Measure the decrease in the intensity of autistic symptoms
Time Frame
Baseline,1-month, 2-month and 3-months
Title
Clinical Global Impression-Improvement (CGI-I)
Description
Measure the global clinical outcome
Time Frame
Baseline,1-month, 2-month and 3-months
Title
Clinical Global Impression-Severity (CGI-S)
Description
Measure the global clinical outcome
Time Frame
Baseline,1-month, 2-month and 3-months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: a current diagnosis of autism, Asperger syndrome, atypical autism according ICD-10 criteria confirmed by specialized clinical assessment; presenting severe behavioural disturbances such as hetero and self-injurious behaviours, automutilation, severe motor hyperactivity, severe stereotypies. having a systematically consultation by a neuro pediatric. Exclusion Criteria: children with known organic syndrome and/or non-stabilized neuropediatric (e.g. seizures) or medical (e.g. diabetes mellitus) comorbidities. patients with stabilized seizure condition, antiepileptic medication should be stable for at least 4 weeks.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre Delion, MD, PhD
Organizational Affiliation
University Hospital, Lille
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre de Santé Mentale Angevin
City
Angers
Country
France
Facility Name
Centre Hospitalier d'Arras
City
Arras
Country
France
Facility Name
Centre Hospitalier Robert Ballanger
City
Aulnay-sous-Bois
Country
France
Facility Name
Centre Hospitalier Montfavet
City
Avignon
Country
France
Facility Name
Institut Départemental Albert Calmette
City
Camiers
Country
France
Facility Name
Centre Hospitalier de Douai
City
Douai
Country
France
Facility Name
Etablissement Public de Santé Roger Prévot
City
Gennevilliers
Country
France
Facility Name
Centre Hospitalier de Lens
City
Lens
Country
France
Facility Name
Hôpital Fontan, CHRU
City
Lille
Country
France
Facility Name
Institut Médico-éducatif
City
Montigny-en-Ostrevent
Country
France
Facility Name
Etablissement de Santé Maison Blanche
City
Paris
Country
France
Facility Name
Groupe Hospitalier Pitier-Salpêtrière
City
Paris
Country
France
Facility Name
Etablissement Public de Santé Mentale Val de Lys-Artois
City
Saint-Venant
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
29958284
Citation
Delion P, Labreuche J, Deplanque D, Cohen D, Duhamel A, Lallie C, Ravary M, Goeb JL, Medjkane F, Xavier J; Therapeutic Body Wrap Study group. Therapeutic body wraps (TBW) for treatment of severe injurious behaviour in children with autism spectrum disorder (ASD): A 3-month randomized controlled feasibility study. PLoS One. 2018 Jun 29;13(6):e0198726. doi: 10.1371/journal.pone.0198726. eCollection 2018.
Results Reference
derived
PubMed Identifier
29927930
Citation
Huang HF, Tian JL, Yang XT, Sun L, Hu RY, Yan ZH, Li SS, Xie Q, Tian XB. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis. PLoS One. 2018 Jun 21;13(6):e0197868. doi: 10.1371/journal.pone.0197868. eCollection 2018.
Results Reference
derived

Learn more about this trial

Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.

We'll reach out to this number within 24 hrs